Combinatorial therapy of gene editing and targeted radiation

The increased efficiency of gene disruption or sequence modification enabled by synthetic CRISPR/Cas 9 (RNPs)provides a unique opportunity to increase the sensitivity of transformed cells to standard anticancer therapy in a combinatorial approach.